How to Buy gland Shares on Fincept?
You can buy Gland Pharma Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: Gland Pharma Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Gland, including updates on board meetings and corporate actions.
Gland Pharma Limited - https://www.glandpharma.com
Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. The company engages in research and development of pharmaceutical active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company offers its products for various therapeutic categories, such as anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastrointestinal, gynaecological, hormones, neuro/Cns, ophthal/otological, and other areas, as well as pain and analgesics, respiratory, and vitamins, minerals, and nutrients; and contract development services. The company was incorporated in 1978 and is headquartered in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Gland Pharma Limited Share Price Today
1,501.00
OPEN
1,527.00
HIGH
1,492.55
LOW
1,506.40
CLOSE
97 K
VOLUME
29,055 Cr
Market Cap
304770
Average Volume
Healthcare
Sector
NSI
Exchange
Gland Pharma Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: GLAND Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Gland Pharma Limited |
GLAND |
INE068V01023 |
Annual General Meeting/Dividend - Rs 20 Per Share |
16 Aug 2024 |
1 |
N/A |
Gland Pharma Limited |
GLAND |
INE068V01023 |
Annual General Meeting |
06 Aug 2021 |
1 |
N/A |
NSE: GLAND Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
GLAND |
27 Dec 2024, 15:40:19 |
Trading Window-XBRL |
N/A |
GLAND |
27 Dec 2024, 15:39:04 |
Trading Window |
N/A |
GLAND |
25 Dec 2024, 14:11:09 |
Updates |
N/A |
GLAND |
13 Dec 2024, 13:32:41 |
Analysts/Institutional Investor Meet/Con. Call Updates |
N/A |
GLAND |
11 Dec 2024, 18:14:30 |
Press Release |
N/A |
NSE: GLAND Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Gland Pharma Limited |
GLAND |
16 Oct 2024, 16:54:00 |
16 Oct 2024, 16:54:00 |
|
Gland Pharma Limited |
GLAND |
15 Jul 2024, 16:32:00 |
15 Jul 2024, 16:32:00 |
|
Gland Pharma Limited |
GLAND |
15 Apr 2024, 12:31:00 |
15 Apr 2024, 13:00:00 |
|
Gland Pharma Limited |
GLAND |
18 Jan 2024, 12:45:00 |
18 Jan 2024, 13:15:00 |
|
Gland Pharma Limited |
GLAND |
17 Oct 2023, 18:00:00 |
17 Oct 2023, 18:30:00 |
NSE: GLAND Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Chairperson & Executive Director-CEO |
15 Apr 1969 |
25 Apr 2019 |
06900659 |
Srinivas Sadu |
Active |
Non-Executive Director |
30 Apr 1972 |
03 Oct 2017 |
07675421 |
Qiyu Chen |
Active |
Independent Director |
23 Nov 1954 |
07 Feb 2018 |
00707474 |
UDO JAHANNES VETTER |
Active |
Independent Director |
01 Feb 1980 |
30 Sep 2020 |
00157299 |
Essaji Goolam Vahanvati |
Active |
Independent Director |
12 Mar 1967 |
20 Nov 2018 |
00142138 |
Satyanarayana Murthy Chavali |
Active |
NSE: GLAND Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
GLAND PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 . |
GLAND |
N/A |
INE068V01023 |
Gland Pharma Limited |
22 Oct 2024, 17:58:18 |
Financial Results |
GLAND |
N/A |
INE068V01023 |
Gland Pharma Limited |
19 Jul 2024, 17:22:21 |
Financial Results/Dividend |
GLAND |
N/A |
INE068V01023 |
Gland Pharma Limited |
09 May 2024, 13:08:37 |
Financial Results |
GLAND |
N/A |
INE068V01023 |
Gland Pharma Limited |
11 Jan 2024, 15:48:02 |
Financial Results |
GLAND |
N/A |
INE068V01023 |
Gland Pharma Limited |
17 Oct 2023, 16:31:02 |
NSE: GLAND Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results |
GLAND |
- |
INE068V01023 |
Gland Pharma Limited |
22 Oct 2024, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2024 |
Financial Results |
GLAND |
- |
INE068V01023 |
Gland Pharma Limited |
19 Jul 2024, 00:00:00 |
To consider and approve the financial results for the period ended Jun 30, 2024 |
Financial Results/Dividend |
GLAND |
- |
INE068V01023 |
Gland Pharma Limited |
09 May 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024 and dividend |
Financial Results |
GLAND |
- |
INE068V01023 |
Gland Pharma Limited |
11 Jan 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2023 |
Financial Results |
GLAND |
- |
INE068V01023 |
Gland Pharma Limited |
17 Oct 2023, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2023 |
NSE: GLAND Balance Sheet Data In (Cr)
| date | period_type | Ordinary Shares Number | Share Issued | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Non Current Pension And Other Postretirement Benefit Plans | Non Current Deferred Revenue | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Debt | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Current Provisions | Payables | Other Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Non Current Deferred Taxes Assets | Investmentin Financial Assets | Available For Sale Securities | Goodwill And Other Intangible Assets | Other Intangible Assets | Goodwill | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Restricted Cash | Prepaid Assets | Inventory | Other Inventories | Finished Goods | Work In Process | Raw Materials | Other Receivables | Taxes Receivable | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 164,751,723.00 | 164,751,723.00 | 3,266,280,000.00 | 84,227,830,000.00 | 90,667,690,000.00 | 48,653,860,000.00 | 84,227,830,000.00 | 478,590,000.00 | 87,880,000,000.00 | 88,816,170,000.00 | 87,880,000,000.00 | 0.00 | 87,880,000,000.00 | 87,715,250,000.00 | 0.00 | 0.00 | 164,750,000.00 | 164,750,000.00 | 20,788,940,000.00 | 5,401,350,000.00 | 461,300,000.00 | 0.00 | 0.00 | 2,191,710,000.00 | 1,254,180,000.00 | 318,010,000.00 | 936,170,000.00 | 1,494,160,000.00 | 15,387,590,000.00 | 1,738,050,000.00 | 2,012,100,000.00 | 160,580,000.00 | 1,851,520,000.00 | 0.00 | 569,290,000.00 | 11,004,990,000.00 | 0.00 | 1,028,330,000.00 | 9,976,660,000.00 | 108,668,940,000.00 | 44,627,490,000.00 | 845,530,000.00 | 0.00 | 527,090,000.00 | 0.00 | 0.00 | 3,652,170,000.00 | 1,124,590,000.00 | 2,527,580,000.00 | 39,327,880,000.00 | 0.00 | 39,327,880,000.00 | 2,766,850,000.00 | 36,561,030,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 64,041,450,000.00 | 4,067,570,000.00 | 0.00 | 0.00 | 15,770,310,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14,899,730,000.00 | 0.00 | 0.00 | 29,303,840,000.00 | 1,102,760,000.00 | 28,201,080,000.00 | 0.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 164,710,523.00 | 164,710,523.00 | 3,721,660,000.00 | 83,693,650,000.00 | 90,436,250,000.00 | 42,467,890,000.00 | 83,693,650,000.00 | 523,840,000.00 | 87,238,430,000.00 | 88,303,830,000.00 | 87,238,430,000.00 | 0.00 | 87,238,430,000.00 | 13,840,000.00 | 67,878,480,000.00 | 19,325,730,000.00 | 164,710,000.00 | 164,710,000.00 | 19,374,030,000.00 | 5,390,400,000.00 | 404,860,000.00 | 1,372,120,000.00 | 404,860,000.00 | 2,201,230,000.00 | 1,412,190,000.00 | 346,790,000.00 | 1,065,400,000.00 | 1,372,120,000.00 | 13,983,630,000.00 | 3,930,000.00 | 2,309,470,000.00 | 177,050,000.00 | 2,132,420,000.00 | 589,070,000.00 | 589,070,000.00 | 10,227,410,000.00 | 1,084,120,000.00 | 516,370,000.00 | 8,626,920,000.00 | 106,612,460,000.00 | 50,160,940,000.00 | 976,200,000.00 | 567,700,000.00 | 504,370,000.00 | 6,545,000,000.00 | 6,545,000,000.00 | 3,544,780,000.00 | 1,122,190,000.00 | 2,422,590,000.00 | 38,710,020,000.00 | -10,449,110,000.00 | 49,159,130,000.00 | 2,787,330,000.00 | 3,267,530,000.00 | 27,844,270,000.00 | 5,943,150,000.00 | 9,316,850,000.00 | 0.00 | 56,451,520,000.00 | 3,398,590,000.00 | 1,006,820,000.00 | 2,381,340,000.00 | 16,552,370,000.00 | 4,654,430,000.00 | 866,210,000.00 | 5,432,520,000.00 | 5,599,210,000.00 | 1,536,590,000.00 | 0.00 | 15,586,900,000.00 | -191,650,000.00 | 15,778,550,000.00 | 19,387,500,000.00 | 15,816,620,000.00 | 3,570,880,000.00 | 0.00 | 3,570,880,000.00 |
| 2024-03-31T00:00:00 | annual | 164,710,523.00 | 164,710,523.00 | 3,721,660,000.00 | 83,693,650,000.00 | 90,436,250,000.00 | 42,467,890,000.00 | 83,693,650,000.00 | 523,840,000.00 | 87,238,430,000.00 | 88,303,830,000.00 | 87,238,430,000.00 | 0.00 | 87,238,430,000.00 | 13,840,000.00 | 67,878,480,000.00 | 19,325,730,000.00 | 164,710,000.00 | 164,710,000.00 | 19,374,030,000.00 | 5,390,400,000.00 | 404,860,000.00 | 1,372,120,000.00 | 404,860,000.00 | 2,201,230,000.00 | 1,412,190,000.00 | 346,790,000.00 | 1,065,400,000.00 | 1,372,120,000.00 | 13,983,630,000.00 | 3,930,000.00 | 2,309,470,000.00 | 177,050,000.00 | 2,132,420,000.00 | 589,070,000.00 | 589,070,000.00 | 10,227,410,000.00 | 1,084,120,000.00 | 516,370,000.00 | 8,626,920,000.00 | 106,612,460,000.00 | 50,160,940,000.00 | 976,200,000.00 | 567,700,000.00 | 504,370,000.00 | 6,545,000,000.00 | 6,545,000,000.00 | 3,544,780,000.00 | 1,122,190,000.00 | 2,422,590,000.00 | 38,710,020,000.00 | -10,449,110,000.00 | 49,159,130,000.00 | 2,787,330,000.00 | 3,267,530,000.00 | 27,844,270,000.00 | 5,943,150,000.00 | 9,316,850,000.00 | 0.00 | 56,451,520,000.00 | 3,398,590,000.00 | 1,006,820,000.00 | 2,381,340,000.00 | 16,552,370,000.00 | 4,654,430,000.00 | 866,210,000.00 | 5,432,520,000.00 | 5,599,210,000.00 | 1,536,590,000.00 | 0.00 | 15,586,900,000.00 | -191,650,000.00 | 15,778,550,000.00 | 19,387,500,000.00 | 15,816,620,000.00 | 3,570,880,000.00 | 0.00 | 3,570,880,000.00 |
| 2023-09-30T00:00:00 | quarterly | 164,700,823.00 | 164,700,823.00 | 3,570,300,000.00 | 76,970,940,000.00 | 86,194,180,000.00 | 44,351,140,000.00 | 76,970,940,000.00 | 443,210,000.00 | 83,067,090,000.00 | 84,272,980,000.00 | 83,067,090,000.00 | 0.00 | 83,067,090,000.00 | 82,902,390,000.00 | 0.00 | 0.00 | 164,700,000.00 | 164,700,000.00 | 19,861,290,000.00 | 4,499,270,000.00 | 437,460,000.00 | 0.00 | 0.00 | 1,338,460,000.00 | 1,474,400,000.00 | 268,510,000.00 | 1,205,890,000.00 | 1,248,950,000.00 | 15,362,020,000.00 | 2,365,970,000.00 | 2,095,900,000.00 | 174,700,000.00 | 1,921,200,000.00 | 0.00 | 397,660,000.00 | 10,397,420,000.00 | 0.00 | 614,940,000.00 | 9,782,480,000.00 | 102,928,380,000.00 | 43,215,220,000.00 | 977,810,000.00 | 0.00 | 443,760,000.00 | 1,180,000,000.00 | 1,180,000,000.00 | 6,096,150,000.00 | 1,540,200,000.00 | 4,555,950,000.00 | 34,132,270,000.00 | 0.00 | 34,132,270,000.00 | 3,200,050,000.00 | 30,932,220,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 59,713,160,000.00 | 2,804,900,000.00 | 0.00 | 0.00 | 20,843,480,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 243,760,000.00 | 0.00 | 13,731,370,000.00 | 0.00 | 0.00 | 22,089,650,000.00 | 17,281,450,000.00 | 4,808,200,000.00 | 0.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 164,700,823.00 | 164,700,823.00 | 44,530,000.00 | 79,470,610,000.00 | 79,625,430,000.00 | 61,716,750,000.00 | 79,470,610,000.00 | 6,320,000.00 | 79,587,220,000.00 | 79,619,830,000.00 | 79,587,220,000.00 | 0.00 | 79,587,220,000.00 | 16,650,000.00 | 60,153,880,000.00 | 19,317,670,000.00 | 164,700,000.00 | 164,700,000.00 | 8,188,130,000.00 | 896,800,000.00 | 0.00 | 0.00 | 0.00 | 842,030,000.00 | 37,440,000.00 | 4,830,000.00 | 32,610,000.00 | 17,330,000.00 | 7,291,330,000.00 | 35,780,000.00 | 7,090,000.00 | 1,490,000.00 | 5,600,000.00 | 313,180,000.00 | 313,180,000.00 | 6,174,860,000.00 | 291,510,000.00 | 9,850,000.00 | 5,873,500,000.00 | 87,775,350,000.00 | 18,767,270,000.00 | 1,064,410,000.00 | 434,800,000.00 | 0.00 | 0.00 | 0.00 | 116,610,000.00 | 116,610,000.00 | 0.00 | 17,990,640,000.00 | -7,230,860,000.00 | 25,221,500,000.00 | 2,401,770,000.00 | 2,057,510,000.00 | 16,788,530,000.00 | 3,327,700,000.00 | 645,990,000.00 | 0.00 | 69,008,080,000.00 | 2,477,790,000.00 | 78,450,000.00 | 1,488,610,000.00 | 19,453,000,000.00 | 3,746,610,000.00 | 886,680,000.00 | 4,614,650,000.00 | 10,205,060,000.00 | 1,645,780,000.00 | 0.00 | 8,713,940,000.00 | -586,880,000.00 | 9,300,820,000.00 | 37,628,300,000.00 | 18,539,350,000.00 | 19,088,950,000.00 | 13,627,000,000.00 | 19,088,950,000.00 |
| 2023-03-31T00:00:00 | annual | 164,700,823.00 | 164,700,823.00 | 44,530,000.00 | 79,470,610,000.00 | 79,625,430,000.00 | 61,716,750,000.00 | 79,470,610,000.00 | 6,320,000.00 | 79,587,220,000.00 | 79,619,830,000.00 | 79,587,220,000.00 | 0.00 | 79,587,220,000.00 | 16,650,000.00 | 60,153,880,000.00 | 19,317,670,000.00 | 164,700,000.00 | 164,700,000.00 | 8,188,130,000.00 | 896,800,000.00 | 0.00 | 0.00 | 0.00 | 842,030,000.00 | 37,440,000.00 | 4,830,000.00 | 32,610,000.00 | 17,330,000.00 | 7,291,330,000.00 | 35,780,000.00 | 7,090,000.00 | 1,490,000.00 | 5,600,000.00 | 313,180,000.00 | 313,180,000.00 | 6,174,860,000.00 | 291,510,000.00 | 9,850,000.00 | 5,873,500,000.00 | 87,775,350,000.00 | 18,767,270,000.00 | 1,064,410,000.00 | 434,800,000.00 | 0.00 | 0.00 | 0.00 | 116,610,000.00 | 116,610,000.00 | 0.00 | 17,990,640,000.00 | -7,230,860,000.00 | 25,221,500,000.00 | 2,401,770,000.00 | 2,057,510,000.00 | 16,788,530,000.00 | 3,327,700,000.00 | 645,990,000.00 | 0.00 | 69,008,080,000.00 | 2,477,790,000.00 | 78,450,000.00 | 1,488,610,000.00 | 19,453,000,000.00 | 3,746,610,000.00 | 886,680,000.00 | 4,614,650,000.00 | 10,205,060,000.00 | 1,645,780,000.00 | 0.00 | 8,713,940,000.00 | -586,880,000.00 | 9,300,820,000.00 | 37,628,300,000.00 | 18,539,350,000.00 | 19,088,950,000.00 | 13,627,000,000.00 | 19,088,950,000.00 |
| 2022-03-31T00:00:00 | annual | 164,302,723.00 | 164,302,723.00 | 47,430,000.00 | 71,450,860,000.00 | 71,615,540,000.00 | 52,700,540,000.00 | 71,450,860,000.00 | 8,100,000.00 | 71,576,210,000.00 | 71,614,420,000.00 | 71,576,210,000.00 | 0.00 | 71,576,210,000.00 | 132,400,000.00 | 52,343,450,000.00 | 18,987,360,000.00 | 164,300,000.00 | 164,300,000.00 | 6,760,000,000.00 | 939,750,000.00 | 0.00 | 0.00 | 0.00 | 877,600,000.00 | 44,820,000.00 | 6,610,000.00 | 38,210,000.00 | 17,330,000.00 | 5,820,250,000.00 | 40,580,000.00 | 2,610,000.00 | 1,490,000.00 | 1,120,000.00 | 247,730,000.00 | 247,730,000.00 | 5,190,170,000.00 | 381,880,000.00 | 179,790,000.00 | 4,628,500,000.00 | 78,336,210,000.00 | 19,815,420,000.00 | 836,150,000.00 | 349,130,000.00 | 0.00 | 2,000,000,000.00 | 2,000,000,000.00 | 125,350,000.00 | 125,350,000.00 | 0.00 | 17,268,970,000.00 | -5,786,840,000.00 | 23,055,810,000.00 | 2,272,390,000.00 | 1,747,270,000.00 | 15,194,800,000.00 | 3,202,870,000.00 | 638,480,000.00 | 0.00 | 58,520,790,000.00 | 1,722,290,000.00 | 265,980,000.00 | 1,253,430,000.00 | 11,856,670,000.00 | 1,774,240,000.00 | 591,470,000.00 | 4,440,690,000.00 | 5,050,270,000.00 | 2,179,490,000.00 | 0.00 | 10,748,050,000.00 | -52,060,000.00 | 10,800,110,000.00 | 32,217,170,000.00 | 29,268,930,000.00 | 2,948,240,000.00 | 450,000,000.00 | 2,498,240,000.00 |
| 2021-03-31T00:00:00 | annual | 163,592,923.00 | 163,592,923.00 | 49,950,000.00 | 59,032,420,000.00 | 59,073,110,000.00 | 46,111,140,000.00 | 59,032,420,000.00 | 9,260,000.00 | 59,032,420,000.00 | 59,071,760,000.00 | 59,032,420,000.00 | 0.00 | 59,032,420,000.00 | 254,200,000.00 | 40,226,810,000.00 | 18,434,530,000.00 | 163,590,000.00 | 163,590,000.00 | 5,928,400,000.00 | 803,120,000.00 | 0.00 | 0.00 | 0.00 | 738,810,000.00 | 46,980,000.00 | 7,640,000.00 | 39,340,000.00 | 17,330,000.00 | 5,125,280,000.00 | 43,760,000.00 | 2,970,000.00 | 1,620,000.00 | 1,350,000.00 | 251,320,000.00 | 251,320,000.00 | 4,484,760,000.00 | 234,370,000.00 | 286,900,000.00 | 3,963,490,000.00 | 64,960,820,000.00 | 13,724,400,000.00 | 713,790,000.00 | 434,990,000.00 | 0.00 | 0.00 | 69,520,000.00 | 0.00 | 0.00 | 0.00 | 13,244,420,000.00 | -4,764,650,000.00 | 18,009,070,000.00 | 3,702,100,000.00 | 1,123,230,000.00 | 10,244,610,000.00 | 2,492,040,000.00 | 447,090,000.00 | 0.00 | 51,236,420,000.00 | 1,292,910,000.00 | 5,592,450,000.00 | 982,590,000.00 | 12,751,680,000.00 | 1,718,000,000.00 | 1,759,290,000.00 | 3,639,770,000.00 | 5,634,620,000.00 | 734,940,000.00 | 0.00 | 6,709,710,000.00 | -14,210,000.00 | 6,723,920,000.00 | 24,465,050,000.00 | 19,546,850,000.00 | 4,918,200,000.00 | 1,869,950,000.00 | 3,048,250,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 95,350,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 299,600,000.00 | 0.00 |
NSE: GLAND Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Repayment Of Debt | Issuance Of Debt | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Beginning Cash Position | Effect Of Exchange Rate Changes | Changes In Cash | Financing Cash Flow | Interest Paid Cff | Net Common Stock Issuance | Common Stock Issuance | Net Issuance Payments Of Debt | Net Long Term Debt Issuance | Long Term Debt Payments | Long Term Debt Issuance | Investing Cash Flow | Interest Received Cfi | Net Investment Purchase And Sale | Sale Of Investment | Purchase Of Investment | Net Business Purchase And Sale | Purchase Of Business | Net Intangibles Purchase And Sale | Purchase Of Intangibles | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Other Current Assets | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Stock Based Compensation | Provisionand Write Offof Assets | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Gain Loss On Investment Securities | Net Foreign Currency Exchange Gain Loss | Gain Loss On Sale Of PPE | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 5,985,410,000.00 | -7,773,060,000.00 | 210,280,000.00 | 5,260,000.00 | -3,982,560,000.00 | 3,570,880,000.00 | 19,088,950,000.00 | 77,230,000.00 | -15,595,300,000.00 | -7,994,160,000.00 | -256,110,000.00 | 5,260,000.00 | 5,260,000.00 | -7,562,780,000.00 | -7,562,780,000.00 | -7,773,060,000.00 | 210,280,000.00 | -17,569,110,000.00 | 1,370,510,000.00 | -4,747,170,000.00 | 2,653,350,000.00 | -7,400,520,000.00 | -10,217,560,000.00 | -10,217,560,000.00 | -83,260,000.00 | -83,260,000.00 | -3,891,630,000.00 | 7,670,000.00 | -3,899,300,000.00 | 9,967,970,000.00 | -3,061,490,000.00 | -531,990,000.00 | 0.00 | -3,788,700,000.00 | 6,660,770,000.00 | -3,300,530,000.00 | -1,288,150,000.00 | 0.00 | 138,360,000.00 | 3,445,660,000.00 | 186,880,000.00 | 3,258,780,000.00 | -3,480,000.00 | -129,720,000.00 | -2,490,000.00 | 11,325,420,000.00 |
| 2023-03-31T00:00:00 | annual | 1,408,490,000.00 | -1,120,000.00 | 0.00 | 214,960,000.00 | -2,231,190,000.00 | 19,088,950,000.00 | 3,188,200,000.00 | 30,000,000.00 | 15,870,750,000.00 | 149,190,000.00 | -62,870,000.00 | 214,960,000.00 | 214,960,000.00 | -1,120,000.00 | -1,120,000.00 | -1,120,000.00 | 0.00 | 12,081,880,000.00 | 1,606,040,000.00 | 12,705,630,000.00 | 17,405,420,000.00 | -4,699,790,000.00 | 0.00 | 0.00 | -21,900,000.00 | -21,900,000.00 | -2,207,890,000.00 | 1,400,000.00 | -2,209,290,000.00 | 3,639,680,000.00 | -3,108,650,000.00 | -4,179,410,000.00 | 356,470,000.00 | 1,209,760,000.00 | -7,596,330,000.00 | 1,799,720,000.00 | -1,166,690,000.00 | 0.00 | 0.00 | 1,467,360,000.00 | 8,740,000.00 | 1,458,620,000.00 | -28,480,000.00 | 23,560,000.00 | 810,000.00 | 10,545,820,000.00 |
| 2022-03-31T00:00:00 | annual | 2,686,500,000.00 | -1,360,000.00 | 0.00 | 385,520,000.00 | -5,221,190,000.00 | 3,188,200,000.00 | 4,924,630,000.00 | 33,110,000.00 | -1,769,540,000.00 | 348,980,000.00 | -34,020,000.00 | 385,520,000.00 | 385,520,000.00 | -1,360,000.00 | -1,360,000.00 | -1,360,000.00 | 0.00 | -10,026,210,000.00 | 1,308,170,000.00 | -6,117,180,000.00 | 10,700,880,000.00 | -16,818,060,000.00 | 0.00 | 0.00 | -107,920,000.00 | -107,920,000.00 | -5,109,280,000.00 | 3,990,000.00 | -5,113,270,000.00 | 7,907,690,000.00 | -4,065,090,000.00 | -3,930,080,000.00 | -1,380,810,000.00 | 659,190,000.00 | 895,010,000.00 | -4,197,830,000.00 | -1,352,430,000.00 | 46,210,000.00 | 37,850,000.00 | 1,102,960,000.00 | 4,470,000.00 | 1,098,490,000.00 | -44,890,000.00 | -77,560,000.00 | 1,780,000.00 | 16,185,520,000.00 |
| 2021-03-31T00:00:00 | annual | 3,761,530,000.00 | -8,910,000.00 | 0.00 | 12,418,070,000.00 | -2,287,760,000.00 | 4,924,630,000.00 | 1,694,970,000.00 | 35,770,000.00 | 3,193,890,000.00 | 12,384,600,000.00 | -23,310,000.00 | 12,418,070,000.00 | 12,418,070,000.00 | -8,910,000.00 | -8,910,000.00 | -8,910,000.00 | 0.00 | -15,240,000,000.00 | 619,370,000.00 | -13,575,910,000.00 | 0.00 | -13,575,910,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2,283,460,000.00 | 4,300,000.00 | -2,287,760,000.00 | 6,049,290,000.00 | -3,114,250,000.00 | -4,357,590,000.00 | 45,590,000.00 | 1,384,410,000.00 | -5,188,890,000.00 | -599,590,000.00 | -830,380,000.00 | 155,340,000.00 | -28,610,000.00 | 987,800,000.00 | 0.00 | 987,800,000.00 | 0.00 | -113,640,000.00 | -240,000.00 | 13,348,100,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 520,570,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 164,840,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: GLAND Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Minority Interests | Net Income Including Noncontrolling Interests | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Write Off | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Amortization | Depreciation Income Statement | Research And Development | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | -2.22 | 0.00 | 1,505.89 | -6.99 | -6.99 | 772.46 | 344.57 | 2,173.09 | 1,498.90 | 1,154.33 | 124.41 | 21.79 | 150.61 | 777.23 | 772.46 | 4,645.64 | 9.92 | 16.47 | 16.47 | 0.00 | 0.00 | 772.46 | 772.46 | 0.00 | 772.46 | 0.00 | 772.46 | 772.46 | 360.08 | 1,132.54 | 8.43 | -7.34 | -0.25 | 7.59 | 124.41 | 4.41 | 21.79 | 150.61 | 996.09 | 2,472.55 | 682.22 | 344.57 | 18.69 | 325.88 | 32.03 | 169.91 | 37.46 | 132.44 | 9.92 | 3,468.64 | 2,173.09 | 5,641.73 | 5,641.73 |
| 2023-03-31T00:00:00 | annual | -16.14 | 0.00 | 1,269.84 | -62.23 | -62.23 | 781.04 | 146.74 | 1,685.43 | 1,207.61 | 1,060.87 | 171.97 | 6.29 | 179.42 | 827.13 | 781.04 | 2,705.22 | 1.42 | 16.47 | 16.46 | 0.00 | 0.00 | 781.04 | 781.04 | 0.00 | 781.04 | 0.00 | 781.04 | 781.04 | 273.54 | 1,054.58 | 1.05 | -65.08 | 56.54 | 8.54 | 171.97 | 1.16 | 6.29 | 179.42 | 886.64 | 1,019.79 | 385.18 | 146.74 | 0.87 | 145.86 | 40.38 | 75.56 | 27.03 | 48.53 | 1.42 | 1,906.43 | 1,685.43 | 3,591.86 | 3,591.86 |
| 2022-03-31T00:00:00 | annual | 1.00 | 0.00 | 1,728.28 | 3.97 | 3.97 | 1,211.66 | 110.30 | 2,109.22 | 1,732.25 | 1,621.95 | 133.40 | 3.40 | 138.65 | 1,208.69 | 1,211.66 | 2,983.77 | 1.12 | 16.45 | 16.42 | 0.00 | 0.00 | 1,211.66 | 1,211.66 | 0.00 | 1,211.66 | 0.00 | 1,211.66 | 1,211.66 | 406.89 | 1,618.55 | 1.60 | -0.52 | 0.18 | 0.34 | 133.40 | 1.84 | 3.40 | 138.65 | 1,400.38 | 874.55 | 327.34 | 110.30 | 0.45 | 109.85 | 42.66 | 71.14 | 40.98 | 30.16 | 1.12 | 2,274.93 | 2,109.22 | 4,384.15 | 4,384.15 |
| 2021-03-31T00:00:00 | annual | -0.06 | 0.00 | 1,436.75 | -0.25 | -0.25 | 996.96 | 98.78 | 1,491.87 | 1,436.50 | 1,337.72 | 82.54 | 2.91 | 85.95 | 997.15 | 996.96 | 2,219.92 | 0.82 | 15.83 | 15.81 | 0.00 | 0.00 | 996.96 | 996.96 | 0.00 | 996.96 | 0.00 | 996.96 | 996.96 | 337.85 | 1,334.81 | 8.28 | -0.25 | -0.02 | 0.28 | 82.54 | 0.50 | 2.91 | 85.95 | 1,203.72 | 728.04 | 270.96 | 98.78 | 0.00 | 98.78 | 32.20 | 53.16 | 36.69 | 16.47 | 0.82 | 1,931.76 | 1,491.87 | 3,423.64 | 3,423.64 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
4/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
42
P/E
41.98929
P/B
3.304849
Dividend Yield
1.13%
Market Cap
29,054.84 Cr.
Face Value
533.625
Book Value
533.625
ROE
11.74%
EBITDA Growth
1,257.26 Cr.
Debt/Equity
3.717
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of gland?
The market capitalization of Gland Pharma Limited is ₹29,055 Cr as of 05 Feb 2025.
What are the PE and PB ratios of Gland Pharma Limited?
The PE and PB ratios of Gland Pharma Limited are Not Available and 3.304849 respectively as of 05 Feb 2025.
What is the 52 Week High of Gland Pharma Limited?
The 52-week high of Gland Pharma Limited is ₹2220.95 as of 05 Feb 2025.
What is the 52 Week Low of Gland Pharma Limited?
The 52-week low of Gland Pharma Limited is ₹1585.7 as of 05 Feb 2025.
What are the earnings per share (EPS) for Gland Pharma Limited?
The Earnings Per Share (EPS) of Gland Pharma Limited is ₹42 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of Gland Pharma Limited?
The Return on Equity (ROE) of Gland Pharma Limited is 11.74% as per the most recent financial year data. Explore more on Fincept.